• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: a phosphoramidate oral prodrug of a unique 6-modified purine nucleotide
Date Designated: 12/18/2023
Orphan Designation: Treatment of disease caused by dengue virus
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Atea Pharmaceuticals Inc.
225 Franklin Street
Suite 2100
Boston, Massachusetts 02110
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-